Make Lab Safety the Default not the Burden

A free 30-minute session on the six principles of LabOps Safety by Design and how the best biotechs are embedding HSE compliance into procurement instead of bolting it on top.

HSE Webinar - LabOps Safety by Design

Hosted by MyAmici experts

Why this webinar, why now

 

The hardest place to manage HSE risk is also the easiest to fix. Most biotech HSE failures don’t start in the lab. They start in the inbox at the moment a scientist clicks “buy now” on a hazardous reagent without an up-to-date risk assessment, or orders a biological material whose containment level no one has independently verified, or accepts a delivery of human tissue without confirming the consent documentation covers the intended use. These are the moments where the highest-consequence risks cross the threshold. They’re also where the biggest improvements are available not from working harder, but from designing the workflow so the safer choice becomes the easier one. This webinar walks through how it’s done. Six principles. Real case studies. Live Q&A. No fluff, no sales pitch, no slide bloat.

 

What you’ll learn

 

Six principles of LabOps Safety by Design. We’ll cover all six in plain terms, with examples drawn from real biotech operations:

 

  • Put safety where decisions happen
  • Make compliance the easiest path
  • Two interception points, not one
  • Scientists assess, systems prompt
  • Audit trails as a by-product
  • A safety culture starts at the top

 

Who should attend

 

This isn’t a generic safety culture talk. It’s specifically designed for: Heads of lab operations and facilities in biotechs scaling from 20 to 200 where informal oversight has stopped working but formal systems haven’t been built yet. HSE managers and compliance leaders who want to embed controls into daily workflows rather than enforce them after the fact. Lab managers and PIs dealing with the day-to-day friction of compliance the missing SDS, the chased-down approval, the audit-week scramble. Procurement leaders in life sciences who recognize that purchase decisions are where the highest-consequence risks enter the buildin. CEOs and CSOs of growing biotechs who understand the legal weight of UK corporate  law and want to know what good looks like If you’ve ever found a hazardous chemical on a shelf with no record of who ordered it or worried that you might this session is for you.

 

Insights, ideas and insider knowledge

Dive into a curated mix of thought leadership, industry insight, and behind-the-scenes biotech lab wins.